Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Droxidopa bulk supplier for pharma manufacturers

Droxidopa 100 mg, 200 mg, 300 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 100 mg, 200 mg, 300 mg

Reference Brands: Northera (USA)

Category: Neurology

Droxidopa is a synthetic amino acid analog and a pro-drug of norepinephrine which is converted to norepinephrine by dopa-decarboxylase. It is indicated for adult patients with symptomatic neurogenic orthostatic hypotension (NOH) caused by primary autonomic failure (such as Parkinson’s disease, Multiple System Atrophy, or pure autonomic failure), dopamine β-hydroxylase deficiency, or non-diabetic autonomic neuropathy. The drug helps prevent dizziness, lightheadedness or fainting upon standing by increasing norepinephrine levels and improving vasoconstriction. Key cautions include risk of supine hypertension

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Droxidopa — third party manufacturing & bulk supply

Droxidopa 100 mg, 200 mg, 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Droxidopa is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Droxidopa listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Droxidopa →
Back to Listing

Frequently Asked Questions

Droxidopa is listed as Capsules in 100 mg, 200 mg, 300 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Droxidopa is referenced against Northera (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Valproic Acid

Strength:
125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL

Form: Tablet / Capsule/ Injection / Oral syrup

Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)

View Details
Ubrogepant

Strength:
50 mg, 100 mg

Form: Tablets

Reference Brands: Ubrelvy (USA/India)

View Details
Tolcapone

Strength:
100 mg

Form: Tablets

Reference Brands: Tasmar (USA/EU)

View Details
Safinamide

Strength:
50 mg ,100 mg

Form: Tablets

Reference Brands: Xadago (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.